respectively), whereas absence of CLI recurrence and WFP were not significantly different.
Objectives: Wound sterilization with multiple sessions of antibiotic bead placement has been described as a method to avoid graft removal in patients presenting with deep wound infection after extremity bypass. The long-term benefits of this approach remain poorly understood. We sought to determine whether graft preservation and wound sterilization with antibiotic beads affect amputation rates and patient survival.
Methods: Patients who underwent operations for aortoiliac or infrainguinal aneurysmal or occlusive arterial disease were retrospectively analyzed. Those who developed deep wound infection within 90 days from the index reconstruction (infection group), had underlying exposed bypass graft, and no evidence of anastomotic or arterial bleeding, were managed with graft preservation and antibiotic bead placement every 3 to 5 days, until wound cultures became negative. This group was compared to a contemporary group of controls who underwent similar interventions but did not develop wound infection postoperatively. Primary outcome was amputation-free survival, defined as survival without major amputation. Secondary outcomes included major amputations and occurrence of anastomotic pseudoaneurysm necessitating repair. Inverse propensity score weighting was used for risk adjustment between the groups.
Results: Over an 8-year period we treated 891 patients (infection: 70, controls: 821). Patients in the infection group had higher body mass index (mean 28.5 vs 26 kg/m 2 ; P < .001) and were more likely to have prosthetic graft and axillofemoral bypass compared to controls. Amputation-free survival for the infection vs the control group was 78% vs 74% at 2 years, 62% vs 64% at 4 years, and 52% vs 54% at 6 years postoperatively (logrank test: P ¼ .88; Fig 1) . Freedom from major amputation for the infection vs the control group was 82.5% vs 83.5% at 2 years, 80.5% vs 78% at 4 years, and 80.5% vs 72% at 6 years postoperatively (log-rank test: P ¼ .59; Fig 2) . In the propensity score adjusted model, the presence of infection did not affect amputation-free survival (hazard ratio, 1.13; P ¼ .6) or major amputation (hazard ratio, 0.89; P ¼ .75). Anastomotic pseudoaneurysms occurred in 0.4% and 5.7% of controls and infected patients, respectively (P ¼ .001), and were treated with interposition graft without complications.
Conclusions: Wound sterilization with serial antibiotic bead exchange and bypass preservation is associated with excellent limb salvage and survival rates, similar to those for noninfected wounds. Close follow-up for timely detection of anastomotic pseudoaneurysm is recommended.
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SS19. Intramuscular Injection of Autologous Bone Marrow Cells to Prevent Amputation in Critical
Methods: This was a double-blinded, placebo-controlled trial designed to assess the safety and efficacy of intramuscular injection of autologous 
